(L to R) Orca Bio co-founders Jeroen Bekaert, Ivan Dimov and Nate Fernhoff
ASH: A cell therapy startup with roots in Irv Weissman's lab nearly wipes out a chronic side effect in early trials
While a hematopoietic stem cell transplant is the best option for some patients with blood cancer, the procedure can lead to dangerous complications, such as …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
